FDA Issues New Kidney Warning For Alli Weight Loss Pill
The FDA has updated the warning label for the over-the-counter weight loss drug Alli to include risks of acute kidney injury and kidney stones. Consumers with a history of kidney issues are advised to consult a doctor, and all users should monitor for specific symptoms like back pain or blood in the urine.
Why it matters
As the only FDA-approved over-the-counter weight loss medication, these safety updates are critical for the millions of users who may be taking the drug without direct medical supervision.
Topline The Food and Drug Administration is warning against new side effects of Haleon s over-the-counter weight loss drug Alli, the only such medication currently available in the U.S. without a prescription, and has approved a new label for the drug that highlights potential kidney problems.
The article reports on factual FDA regulatory updates and health warnings without injecting opinion or political framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in